Please Wait.....
Report
NA Fecal Occult Blood Tests Market - Industry Trends and Forecast to 2030
Market Report I 2023-01-01 I 224 Pages I Data Bridge Market Research
North America fecal occult blood testing market is projected to register a substantial CAGR of 5.9 % in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentation
North America Fecal Occult Blood Tests Market, By Test Type (Lateral Flow Immuno-Fob Test Kits, Immuno-FOB Agglutination Test Kits, Immuno-FOB ELISA Test Kits, Guaiac FOB Stool Test, Flushable Reagent Pad or Tissue, and Others), By Application (Colorectal Cancer Screening, Concern for Gastrointestinal Bleeding, Polyps, Diverticulosis, Ulcers, Haemorrhoids, Colitis, Anemia, and Others), By End User (Diagnostic Laboratories, Hospitals, Speciality Clinics, and Others), By Distribution Channel (Direct Sales, Retail Sales, E-Commerce, and Others), Country (U.S., Canada, Mexico.), Industry Trends and Forecast to 2030.
Some of the major factors contributing to the growth of the North America fecal occult blood testing market are:
- Rising cases of colorectal cancer globally
- Development of direct-to-consumer laboratory testing
- Increasing inclination towards point-of-care diagnostics
- Easy availability of fecal occult immunological test devices in online stores
Market Players
Some of the key market players for the North America fecal occult blood testing market are listed below:
- Quidel Corporation
- Siemens Healthcare GmbH
- Biohit Oyj
- Accubiotech Co.Ltd.
- Accuquik Test Kits
- Aidian
- Alfa Scientific Designs, Inc.
- Apacor Limited
- Others
TABLE OF CONTENTS
1 INTRODUCTION 74
1.1 OBJECTIVES OF THE STUDY 74
1.2 MARKET DEFINITION 74
1.3 OVERVIEW OF THE NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET 74
1.4 CURRENCY AND PRICING 76
1.5 LIMITATIONS 76
1.6 MARKETS COVERED 76
2 MARKET SEGMENTATION 80
2.1 MARKETS COVERED 80
2.2 GEOGRAPHICAL SCOPE 81
2.3 YEARS CONSIDERED FOR THE STUDY 82
2.4 DBMR TRIPOD DATA VALIDATION MODEL 83
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 86
2.6 MULTIVARIATE MODELLING 87
2.7 PRODUCT TYPE SEGMENT LIFELINE CURVE 87
2.8 MARKET APPLICATION COVERAGE GRID 88
2.9 DBMR MARKET POSITION GRID 89
2.10 VENDOR SHARE ANALYSIS 90
2.11 SECONDARY SOURCES 91
2.12 ASSUMPTIONS 91
3 EXECUTIVE SUMMARY 92
4 PREMIUM INSIGHTS 94
4.1 PESTEL ANALYSIS 95
4.2 PORTER'S 5 FORCES 96
5 INDUSTRY INSIGHTS 97
6 REGULATORY FRAMEWORK 99
6.1 REGULATORY SCENARIO BY U.S. FDA 99
6.2 REGULATORY SCENARIO IN U.S. 99
6.3 REGULATORY SCENARIO IN EUROPE 100
6.4 REGULATORY SCENARIO IN CANADA 100
6.5 REGULATORY SCENARIO IN AUSTRALIA 100
7 MARKET OVERVIEW 101
7.1 DRIVERS 103
7.1.1 RISING CASES OF COLORECTAL CANCER NORTH AMERICALY 103
7.1.2 DEVELOPMENT OF DIRECT-TO-CONSUMER LABORATORY TESTING 103
7.1.3 EASY AVAILABILITY OF FECAL OCCULT IMMUNOLOGICAL TEST DEVICES IN ONLINE STORES 104
7.1.4 INCREASING INCLINATION TOWARDS POINT-OF-CARE DIAGNOSTICS 104
7.2 RESTRAINTS 104
7.2.1 CHANGE IN CONSUMER PREFERENCE TOWARDS COST-EFFECTIVE ALTERNATIVES 104
7.2.2 LOW AWARENESS ABOUT FECAL OCCULT BLOOD TESTS IN UNDEVELOPED COUNTRIES 105
7.3 OPPORTUNITIES 105
7.3.1 INCREASE IN SCREENING PROCEDURES 105
7.3.2 RISING TECHNICAL ADVANCEMENTS 106
7.3.3 STRATEGIC INITIATIVES 106
7.4 CHALLENGES 107
7.4.1 LACK OF SKILLED PROFESSIONALS 107
7.4.2 LOW EFFICIENCY 107
8 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE 108
8.1 OVERVIEW 109
8.2 LATERAL FLOW IMMUNO-FOB TEST KITS 112
8.3 IMMUNO-FOB AGGLUTINATION TEST KITS 112
8.4 IMMUNO-FOB ELISA TEST KITS 113
8.5 GUAIAC FOB STOOL TEST 114
8.5.1 KITS 115
8.5.1.1 GUAIAC SLIDES 115
8.5.1.1.1 25 PACKAGE 115
8.5.1.1.2 20 PACKAGE 115
8.5.1.1.3 OTHERS 115
8.5.1.2 ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER 116
8.5.1.2.1 SENSITIVITY IS 50NG/ML 116
8.5.1.2.1.1 25 PACKAGE 116
8.5.1.2.1.2 20 PACKAGE 116
8.5.1.2.1.3 OTHERS 117
8.5.1.2.2 SENSITIVITY IS 75NG/ML 117
8.5.1.2.2.1 25 PACKAGE 117
8.5.1.2.2.2 20 PACKAGE 117
8.5.1.2.2.3 OTHERS 117
8.5.1.2.3 OTHERS 117
8.5.1.3 OTHERS 118
8.5.2 REAGENTS 118
8.5.2.1 HYDROGEN PEROXIDE 118
8.5.2.2 OTHERS 118
8.6 FLUSHABLE REAGENT PAD OR TISSUE 118
8.7 OTHERS 119
9 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION 120
9.1 OVERVIEW 121
9.2 COLORECTAL CANCER SCREENING 124
9.2.1 LATERAL FLOW IMMUNO-FOB TEST KITS 125
9.2.2 IMMUNO-FOB AGGLUTINATION TEST KITS 125
9.2.3 IMMUNO-FOB ELISA TEST KITS 125
9.2.4 GUAIAC FOB STOOL TEST 125
9.2.5 FLUSHABLE REAGENT PAD OR TISSUE 125
9.2.6 OTHERS 125
9.3 CONCERN FOR GASTROINTESTINAL BLEEDING 125
9.3.1 LATERAL FLOW IMMUNO-FOB TEST KITS 126
9.3.2 IMMUNO-FOB AGGLUTINATION TEST KITS 126
9.3.3 IMMUNO-FOB ELISA TEST KITS 126
9.3.4 GUAIAC FOB STOOL TEST 127
9.3.5 FLUSHABLE REAGENT PAD OR TISSUE 127
9.3.6 OTHERS 127
9.4 POLYPS 127
9.4.1 LATERAL FLOW IMMUNO-FOB TEST KITS 128
9.4.2 IMMUNO-FOB AGGLUTINATION TEST KITS 128
9.4.3 IMMUNO-FOB ELISA TEST KITS 128
9.4.4 GUAIAC FOB STOOL TEST 128
9.4.5 FLUSHABLE REAGENT PAD OR TISSUE 128
9.4.6 OTHERS 128
9.5 DIVERTICULOSIS 129
9.5.1 LATERAL FLOW IMMUNO-FOB TEST KITS 130
9.5.2 IMMUNO-FOB AGGLUTINATION TEST KITS 130
9.5.3 IMMUNO-FOB ELISA TEST KITS 130
9.5.4 GUAIAC FOB STOOL TEST 130
9.5.5 FLUSHABLE REAGENT PAD OR TISSUE 130
9.5.6 OTHERS 130
9.6 ULCERS 130
9.6.1 LATERAL FLOW IMMUNO-FOB TEST KITS 131
9.6.2 IMMUNO-FOB AGGLUTINATION TEST KITS 131
9.6.3 IMMUNO-FOB ELISA TEST KITS 131
9.6.4 GUAIAC FOB STOOL TEST 132
9.6.5 FLUSHABLE REAGENT PAD OR TISSUE 132
9.6.6 OTHERS 132
9.7 HAEMORRHOIDS 132
9.7.1 LATERAL FLOW IMMUNO-FOB TEST KITS 133
9.7.2 IMMUNO-FOB AGGLUTINATION TEST KITS 133
9.7.3 IMMUNO-FOB ELISA TEST KITS 133
9.7.4 GUAIAC FOB STOOL TEST 133
9.7.5 FLUSHABLE REAGENT PAD OR TISSUE 133
9.7.6 OTHERS 133
9.8 COLITIS 134
9.8.1 LATERAL FLOW IMMUNO-FOB TEST KITS 135
9.8.2 IMMUNO-FOB AGGLUTINATION TEST KITS 135
9.8.3 IMMUNO-FOB ELISA TEST KITS 135
9.8.4 GUAIAC FOB STOOL TEST 135
9.8.5 FLUSHABLE REAGENT PAD OR TISSUE 135
9.8.6 OTHERS 135
9.9 ANEMIA 135
9.9.1 LATERAL FLOW IMMUNO-FOB TEST KITS 136
9.9.2 IMMUNO-FOB AGGLUTINATION TEST KITS 136
9.9.3 IMMUNO-FOB ELISA TEST KITS 136
9.9.4 GUAIAC FOB STOOL TEST 137
9.9.5 FLUSHABLE REAGENT PAD OR TISSUE 137
9.9.6 OTHERS 137
9.10 OTHERS 137
10 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY END USER 138
10.1 OVERVIEW 139
10.2 DIAGNOSTIC LABORATORIES 142
10.3 HOSPITALS 142
10.4 SPECIALITY CLINICS 143
10.5 OTHERS 144
11 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL 145
11.1 OVERVIEW 146
11.2 DIRECT TENDER 149
11.3 RETAIL SALE 149
11.4 E-COMMERCE 150
11.5 OTHERS 151
12 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY REGION 152
12.1 NORTH AMERICA 153
12.1.1 U.S. 166
12.1.2 CANADA 174
12.1.3 MEXICO 182
13 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: COMPANY LANDSCAPE 190
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 190
14 SWOT ANALYSIS 191
15 COMPANY PROFILE 192
15.1 QUIDEL CORPORATION 192
15.1.1 COMPANY SNAPSHOT 192
15.1.2 REVENUE ANALYSIS 192
15.1.3 COMPANY SHARE ANALYSIS 193
15.1.4 PRODUCT PORTFOLIO 193
15.1.5 RECENT DEVELOPMENT 193
15.2 WONDFO. 194
15.2.1 COMPANY SNAPSHOT 194
15.2.2 COMPANY SHARE ANALYSIS 194
15.2.3 PRODUCT PORTFOLIO 195
15.2.4 RECENT DEVELOPMENT 195
15.3 SIEMENS HEALTHCARE GMBH 196
15.3.1 COMPANY SNAPSHOT 196
15.3.2 REVENUE ANALYSIS 196
15.3.3 COMPANY SHARE ANALYSIS 197
15.3.4 RODUCT PORTFOLIO 197
15.3.5 RECENT DEVELOPMENT 197
15.4 EIKEN CHEMICAL CO., LTD. 198
15.4.1 COMPANY SNAPSHOT 198
15.4.2 REVENUE ANALYSIS 198
15.4.3 COMPANY SHARE ANALYSIS 199
15.4.4 PRODUCT PORTFOLIO 199
15.4.5 RECENT DEVELOPMENT 199
15.5 BIOHIT OYJ 200
15.5.1 COMPANY SNAPSHOT 200
15.5.2 REVENUE ANALYSIS 200
15.5.3 COMPANY SHARE ANALYSIS 201
15.5.4 PRODUCT PORTFOLIO 201
15.5.5 RECENT DEVELOPMENT 201
15.6 ACCUBIOTECH CO LTD 202
15.6.1 COMPANY SNAPSHOT 202
15.6.2 PRODUCT PORTFOLIO 202
15.6.3 RECENT DEVELOPMENT 202
15.7 ACCUQUIK TEST KITS 203
15.7.1 COMPANY SNAPSHOT 203
15.7.2 PRODUCT PORTFOLIO 203
15.7.3 RECENT DEVELOPMENT 203
15.8 AIDIAN 204
15.8.1 COMPANY PROFILE 204
15.8.2 PRODUCT PORTFOLIO 204
15.8.3 RECENT DEVELOPMENT 204
15.9 ALFA SCIENTIFIC DESIGNS, INC. 205
15.9.1 COMPANY SNAPSHOT 205
15.9.2 PRODUCT PORTFOLIO 205
15.9.3 RECENT DEVELOPMENT 205
15.10 APACOR LIMITED 206
15.10.1 COMPANY SNAPSHOT 206
15.10.2 PRODUCT PORTFOLIO 206
15.10.3 RECENT DEVELOPMENT 206
15.11 BIOPANDA REAGENTS LTD 207
15.11.1 COMPANY SNAPSHOT 207
15.11.2 PRODUCT PORTFOLIO 207
15.11.3 RECENT DEVELOPMENT 207
15.12 BODITECH MED INC. 208
15.12.1 COMPANY SNAPSHOT 208
15.12.2 PRODUCT PORTFOLIO 208
15.12.3 RECENT DEVELOPMENT 208
15.13 CENOGENICS CORPORATION 209
15.13.1 COMPANY SNAPSHOT 209
15.13.2 PRODUCT PORTFOLIO 209
15.13.3 RECENT DEVELOPMENT 209
15.14 CERTEST BIOTEC. 210
15.14.1 COMPANY SNAPSHOT 210
15.14.2 PRODUCT PORTFOLIO 210
15.14.3 RECENT DEVELOPMENT 210
15.15 CTK BIOTECH, INC. 211
15.15.1 COMPANY SNAPSHOT 211
15.15.2 PRODUCT PORTFOLIO 211
15.15.3 RECENT DEVELOPMENT 211
15.16 EDP BIOTECH 212
15.16.1 COMPANY SNAPSHOT 212
15.16.2 PRODUCT PORTFOLIO 212
15.16.3 1.16.3 RECENT DEVELOPMENT 212
15.17 EPITOPE DIAGNOSTICS, INC. 213
15.17.1 COMPANY SNAPSHOT 213
15.17.2 PRODUCT PORTFOLIO 213
15.17.3 RECENT DEVELOPMENT 213
15.18 EUROLYSER DIAGNOSTICA GMBH 214
15.18.1 COMPANY SNAPSHOT 214
15.18.2 PRODUCT PORTFOLIO 214
15.18.3 RECENT DEVELOPMENT 214
15.19 FIRSTEP 215
15.19.1 COMPANY SNAPSHOT 215
15.19.2 PRODUCT PORTFOLIO 215
15.19.3 RECENT DEVELOPMENT 215
15.20 HANGZHOU CLONGENE BIOTECH CO., LTD 216
15.20.1 COMPANY SNAPSHOT 216
15.20.2 PRODUCT PORTFOLIO 216
15.20.3 RECENT DEVELOPMENT 216
15.21 HUMASIS.COM 217
15.21.1 COMPANY SNAPSHOT 217
15.21.2 PRODUCT PORTFOLIO 217
15.21.3 RECENT DEVELOPMENT 217
15.22 JANT PHARMACAL CORPORATION 218
15.22.1 COMPANY SNAPSHOT 218
15.22.2 PRODUCT PORTFOLIO 218
15.22.3 RECENT DEVELOPMENT 218
15.23 PRIMA LAB SA 219
15.23.1 COMPANY SNAPSHOT 219
15.23.2 PRODUCT PORTFOLIO 219
15.23.3 RECENT DEVELOPMENT 219
15.24 ULTI MED PRODUCTS (DEUTSCHLAND) GMBH 220
15.24.1 COMPANY SNAPSHOT 220
15.24.2 PRODUCT PORTFOLIO 220
15.24.3 RECENT DEVELOPMENT 220
16 QUESTIONNAIRE 221
17 RELATED REPORTS 224
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security